• careers
• investors
• news
• suppliers
• alumni
• login
  • North, Central, or South America
  • Europe, Middle East, or Africa
  • Japan, Asia, or Austrailia/New Zealand
• worldwide
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Denmark
  • Ecuador
  • Estonia
  • Finland

  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • India
  • Ireland
  • Italy
  • Japan
  • Korea
  • Latin America
  • Mexico
  • Netherlands
  • Norway

  • Pakistan
  • Peru
  • Philippines
  • Russia
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey
  • United Kingdom
  • Venezuela

Eli Lilly and Company

Eli Lilly and Company

• home
• about

  About

  Heritage

  Key Facts

  Global Business Areas

  Board of Directors

  Executives

  Corporate Governance

  Business Practices

  Key Issues

  Diversity

  Lilly Foundation

  Lilly Grant Office

  The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. At the heart of Lilly's operations are its core values - excellence, integrity and respect for people.

  Lilly is about more than creating medicines.

  
• responsibility

  Responsibility

  Our Approach

  Ethical Business

  Access to Medicines

  Medicine Development

  Workplace

  Communities

  Patients

  Environmental Sustainability

  How Lilly conducts its business is equally as important as the work it does on a daily basis. Lilly's core values - integrity, excellence and respect for people - are reflected in business practices that include strong governance principles, the ethical development of medicines, transparency and ethical product promotion.

  Responsibility is not a fad. It is at the core of who we are.

  
• products

  Products

  Human

  Animal

  Patient Safety

  Anti-Counterfeiting

  Lilly's innovative products focus on meeting medical needs in the fields of oncology, cardiovascular, diabetes, critical care, neuroscience, men's health and musculoskeletal. Additionally, Elanco, a division of Eli Lilly and Company, works to provide an equally high standard of quality care and product development for animals.

  Our products help shape patient care worldwide.

  
• r & d

  R & D

  Approach to R&D

  Clinical Development Pipeline

  Open Innovation

  Innovation Starts Here

  Global External R&D

  Partnering

  R&D Locations

  More than 7,300 people comprise Lilly Research Laboratories (LRL), which operates in more than 50 countries worldwide. LRL works to discover and develop innovative therapies for many of the world's unmet medical needs, while also providing ongoing scientific support for marketed products.

  Research is the backbone of Lilly.

  

• This Site: Speeches & Presentations lilly.com Advanced Search